3 Comments

They spend billions on drugs that never make it to market so I don’t know why it’s seen as bad when a drug company goes all in on something that does work. Blame the FDA for allowing separate patents on racemic mixtures and pure enantiomers. I’m pretty sure that going forward they’re not allowing this with new drugs.

Also, I don’t think omeprazole is an H1 blocker at all. May want to correct that section.

Expand full comment